一项与倾向分数匹配的研究,包括25万患有V因子莱登的患者,显示与没有血栓友爱症的个体相比,死亡率显著增加
Moritz Hertel1, Max Heiland1, Susanne Nahles1
1Department Oral and Maxillofacial Surgery, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.
Public health in practice (Oxford, England)
|February 25, 2026
概括
维因子 (FVL) 增加了静脉血栓塞栓症的风险. 这项研究发现,FVL也与较高的全因死亡率有关,特别是在年轻女性中,影响生存概率.
科学领域:
- 血液学 血液学 血液学
- 遗传学 是一个遗传学.
- 流行病学 流行病学
背景情况:
- 因素V莱登 (FVL) 是一种普遍存在的遗传性血栓性病.
- FVL增加了静脉血栓塞栓症 (VTE) 的风险.
- 在FVL和全因死亡率之间的关联仍然不完全理解.
研究的目的:
- 调查FVL和全因死亡率之间的关系.
- 使用大型国际数据库进行年龄和性别分层分析.
- 为了澄清FVL对长期生存的影响.
主要方法:
- 使用现实世界电子健康记录进行的回顾性队列研究.
- 分析了241,572名患有FVL的患者,与20,779,115名对照人群相比.
- 倾向性得分与年龄和19年的随访期相匹配.
主要成果:
- FVL与VTE (OR:9.325) 和所有原因死亡率 (OR:1.423) 都有显著的相关性.
- 在年轻女性中观察到较高的死亡风险 (<20岁:OR:9.681;20-50岁:OR:2.345).
- 卡普兰-梅尔分析显示,在各个子组的FVL阳性个体中,生存率降低.
结论:
- FVL是血栓形成的重要危险因素,并增加了全因死亡率.
- 患有FVL的年轻女性面临着特别高的死亡风险.
- 研究结果表明,这对FVL查和风险分层策略有影响.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.1K
Disorders of Hemostasis
2.4K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.4K
Factors Affecting Protein-Drug Binding: Patient-Related Factors
382
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
382
Relative Risk
2.3K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.3K
Venous Thrombosis III: Interprofessional Care
400
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
400
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
391
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
391


